ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 156 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2017. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,798,350 | -22.7% | 359,000 | 0.0% | 0.23% | -17.9% |
Q2 2023 | $16,560,670 | +15.0% | 359,000 | 0.0% | 0.28% | +6.1% |
Q1 2023 | $14,395,900 | -13.4% | 359,000 | 0.0% | 0.26% | -19.5% |
Q4 2022 | $16,632,470 | +31.3% | 359,000 | +17.4% | 0.33% | +31.7% |
Q3 2022 | $12,663,000 | +89.8% | 305,800 | +249.9% | 0.25% | +1.6% |
Q3 2018 | $6,672,000 | -0.7% | 87,400 | 0.0% | 0.24% | -12.2% |
Q2 2018 | $6,718,000 | +50.7% | 87,400 | 0.0% | 0.28% | +33.5% |
Q1 2018 | $4,457,000 | +9.9% | 87,400 | 0.0% | 0.21% | -0.9% |
Q4 2017 | $4,054,000 | -12.9% | 87,400 | 0.0% | 0.21% | -20.1% |
Q3 2017 | $4,655,000 | -14.2% | 87,400 | 0.0% | 0.26% | -21.9% |
Q2 2017 | $5,428,000 | -8.4% | 87,400 | 0.0% | 0.34% | -13.8% |
Q1 2017 | $5,924,000 | -3.6% | 87,400 | 0.0% | 0.39% | -2.0% |
Q4 2016 | $6,145,000 | -0.9% | 87,400 | 0.0% | 0.40% | +5.5% |
Q3 2016 | $6,200,000 | +45.0% | 87,400 | 0.0% | 0.38% | +44.7% |
Q2 2016 | $4,275,000 | -22.7% | 87,400 | 0.0% | 0.26% | -15.2% |
Q1 2016 | $5,533,000 | -43.6% | 87,400 | 0.0% | 0.31% | -36.9% |
Q4 2015 | $9,805,000 | -3.5% | 87,400 | -17.2% | 0.49% | -16.9% |
Q3 2015 | $10,161,000 | +18.0% | 105,500 | +25.4% | 0.59% | +26.6% |
Q2 2015 | $8,611,000 | +101.0% | 84,100 | +21.9% | 0.47% | +44.7% |
Q1 2015 | $4,284,000 | +85.6% | 69,000 | +31.2% | 0.32% | +27.8% |
Q4 2014 | $2,308,000 | -22.5% | 52,600 | 0.0% | 0.25% | -39.4% |
Q3 2014 | $2,977,000 | +26.1% | 52,600 | 0.0% | 0.42% | +29.6% |
Q2 2014 | $2,361,000 | – | 52,600 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |